Cwm, LLC United Therapeutics Corp Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cwm, LLC holds 1,707 shares of UTHR stock, worth $480,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,707

Previous 4,891 65.1%

Holding current value

$480,281

Previous $1.73 Million 69.52%

% of portfolio

0.0%

Previous 0.01%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$304.42 - $380.78 $969,273 - $1.21 Million	-3,184 Reduced 65.1%	1,707 $526,000
Q4 2024 Feb 04, 2025	BUY	$348.66 - $410.0 $308,564 - $362,850	885 Added 22.09%	4,891 $1.73 Million
Q3 2024 Oct 08, 2024	BUY	$311.04 - $363.55 $647,896 - $757,274	2,083 Added 108.32%	4,006 $1.44 Million
Q2 2024 Jul 09, 2024	BUY	$228.26 - $319.04 $43,597 - $60,936	191 Added 11.03%	1,923 $613,000
Q1 2024 Apr 05, 2024	BUY	$210.76 - $249.51 $223,827 - $264,979	1,062 Added 158.51%	1,732 $398,000
Q4 2023 Feb 01, 2024	BUY	$214.88 - $256.94 $45,124 - $53,957	210 Added 45.65%	670 $147,000
Q3 2023 Oct 11, 2023	SELL	$211.82 - $248.24 $2,753 - $3,227	-13 Reduced 2.75%	460 $104,000
Q2 2023 Aug 03, 2023	SELL	$205.19 - $232.99 $11,901 - $13,513	-58 Reduced 10.92%	473 $104,000
Q1 2023 Apr 28, 2023	BUY	$212.99 - $276.17 $15,548 - $20,160	73 Added 15.94%	531 $119,000
Q4 2022 Feb 01, 2023	BUY	$205.95 - $280.43 $29,656 - $40,381	144 Added 45.86%	458 $127,000
Q3 2022 Oct 27, 2022	BUY	$203.3 - $244.17 $36,390 - $43,706	179 Added 132.59%	314 $66,000
Q2 2022 Jul 28, 2022	SELL	$174.81 - $241.14 $1,048 - $1,446	-6 Reduced 4.26%	135 $32,000
Q1 2022 Apr 21, 2022	BUY	$166.16 - $213.96 $6,812 - $8,772	41 Added 41.0%	141 $25,000
Q4 2021 Jan 31, 2022	BUY	$184.32 - $216.08 $8,110 - $9,507	44 Added 78.57%	100 $22,000
Q1 2021 Sep 15, 2021	SELL	$153.94 - $174.85 $23,244 - $26,402	-151 Reduced 72.95%	56 $10,000
Q1 2021 Apr 27, 2021	BUY	$153.94 - $174.85 $23,244 - $26,402	151 Added 269.64%	207 $35,000
Q4 2020 Sep 15, 2021	SELL	$101.87 - $151.79 $15,382 - $22,920	-151 Reduced 72.95%	56 $10,000
Q4 2020 Jan 27, 2021	BUY	$101.87 - $151.79 $15,382 - $22,920	151 Added 269.64%	207 $31,000
Q3 2020 Sep 15, 2021	SELL	$99.9 - $121.13 $15,084 - $18,290	-151 Reduced 72.95%	56 $10,000
Q3 2020 Oct 19, 2020	BUY	$99.9 - $121.13 $15,084 - $18,290	151 Added 269.64%	207 $21,000
Q2 2020 Sep 15, 2021	SELL	$92.74 - $125.82 $14,003 - $18,998	-151 Reduced 72.95%	56 $10,000
Q2 2020 Jul 22, 2020	BUY	$92.74 - $125.82 $14,003 - $18,998	151 Added 269.64%	207 $25,000
Q1 2020 Sep 15, 2021	BUY	$79.39 - $115.35 $2,381 - $3,460	30 Added 115.38%	56 $10,000
Q1 2020 Apr 28, 2020	SELL	$79.39 - $115.35 $2,381 - $3,460	-30 Reduced 53.57%	26 $2,000
Q4 2019 Sep 14, 2021	BUY	$78.31 - $95.34 $4,385 - $5,339	56 New	56 $10,000
Q4 2019 Jan 27, 2020	SELL	$78.31 - $95.34 $4,385 - $5,339	-56 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$74.85 - $85.99 $4,191 - $4,815	56 New	56 $10,000
Q3 2019 Oct 22, 2019	SELL	$74.85 - $85.99 $4,191 - $4,815	-56 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$76.06 - $120.81 $4,259 - $6,765	56 New	56 $10,000
Q2 2019 Jul 31, 2019	SELL	$76.06 - $120.81 $4,259 - $6,765	-56 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$107.15 - $126.84 $6,000 - $7,103	56 New	56 $0
Q1 2019 Apr 22, 2019	SELL	$107.15 - $126.84 $1,285 - $1,522	-12 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$101.4 - $128.73 $4,563 - $5,792	-45 Reduced 78.95%	12 $1,000
Q3 2018 Oct 29, 2018	BUY	$113.81 - $129.46 $796 - $906	7 Added 14.0%	57 $7,000
Q1 2018 Apr 26, 2018	SELL	$107.21 - $151.94 $5,360 - $7,597	-50 Reduced 50.0%	50 $6,000
Q3 2017 Oct 16, 2017	BUY	$114.6 - $136.81 $11,460 - $13,681	100	100 $12,000

Others Institutions Holding UTHR

# of Institutions

733

Shares Held

43.6M

Call Options Held

124K

Put Options Held

122K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $12.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account